Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Pfizer posts unexpected Q4 earnings beat
11:29am, Tuesday, 30'th Jan 2024
Pfizer (PFE) shares are on the move after posting a mixed fourth-quarter earnings report, with adjusted earnings topping expectations, but missing revenue estimates. The pharmaceutical giant saw a sma
GM Up on Q4 Beat & Raise; UPS, Pfizer Mixed
11:26am, Tuesday, 30'th Jan 2024
Aside from a cavalcade of earnings, Case-Shiller came in lower month over month and JOLTS are out after the open.
Pfizer Reports Earnings; Stock Eyes 10th-Straight Monthly Loss
11:25am, Tuesday, 30'th Jan 2024
Pfizer Inc (NYSE:PFE) entered the earnings ring before the bell this morning, announcing fourth-quarter earnings of 10 cents per share, which is higher than analysts' anticipated losses of 22 cents.
Pfizer Q4 Earnings Eke Out Unexpected Profit Despite Lower COVID Product Sales
10:15am, Tuesday, 30'th Jan 2024
Pfizer Inc. (PFE) delivered a surprise profit in the fourth quarter despite a double-digit contraction in revenue. Pfizer shares were up 1.8% in early trading Tuesday following the release.
Pfizer (PFE) Surpasses Q4 Earnings Estimates
08:56am, Tuesday, 30'th Jan 2024
Pfizer (PFE) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.19 per share. This compares to earnings of $1.14 per share a year ago.
BofA's Geoff Meacham on Pfizer earnings: The story is still about Covid contraction
08:55am, Tuesday, 30'th Jan 2024
Geoff Meacham, Bank of America Securities senior pharmaceuticals analyst, joins 'Squawk Box' to break down Pfizer's quarterly earnings results, Big Pharma 2024 outlook, and more.
Pfizer beats earnings estimates as declining Covid business performs better than expected
08:03am, Tuesday, 30'th Jan 2024
CNBC's Mike Santoli reports on the company's quarterly earnings results.
Pfizer's stock rises as earnings beat expectations, company seeks ‘clean slate' in 2024
07:23am, Tuesday, 30'th Jan 2024
Shares of Pfizer Inc. PFE, +0.04% gained 0.7% early Tuesday after the company beat analysts' earnings expectations and reaffirmed its full-year 2024 guidance issued in December.
Pfizer beats earnings estimates as declining Covid business performs better than expected
07:16am, Tuesday, 30'th Jan 2024
Pfizer reversed roughly $3.5 billion in revenue related to the expected return of 6.5 million doses of its Covid drug, Paxlovid, from the U.S. government.
Is there a doctor in the house? Pfizer reports critically low income and revenues in financial results
07:10am, Tuesday, 30'th Jan 2024
Pharmaceutical giant Pfizer on January 30th reported its financial results for Q4 and the full year of 2023. The company reported disappointing results, to say the least, including $58.5 billion in re
Pfizer posts surprise quarterly profit on resilient COVID products demand
06:51am, Tuesday, 30'th Jan 2024
Pfizer reported a surprise quarterly profit on Tuesday, as COVID products demand was better than the company's expectations and research costs declined.
Markets Stroll Higher Ahead of Key Data; SMCI, FFIV, WHR Beat
07:11pm, Monday, 29'th Jan 2024
A sixth record closing high for the S&P 500 just this month/year alone ought to give a good impression of where the market's collective head is at presently.
7 High-Yield Dividend Stocks With High-Upside Potential
04:17pm, Monday, 29'th Jan 2024
High-yield dividend stocks with potential for upside gains is essentially the Tony Robbins of market opportunities. Robbins gives you a big smile, a warm hug and invites into a total transformation pa
Big Earnings Week Ahead
11:36am, Monday, 29'th Jan 2024
Who says January's a long month? This week starts slow, but we'll end it with a full-fledged Jobs Week for February.
Pharma industry to get US government price cut proposals by Thursday
11:35am, Monday, 29'th Jan 2024
Pharmaceutical companies are due to receive by Thursday the U.S. government's opening proposal for discounts it is seeking on 10 high-cost medicines, an important step in the Medicare health program's
